Antibodies to oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia

Hypertension in Pregnancy

Volumn 15, Issue 2, 1996, Pages 251-256

  Kurki, Tapio ^a   Ailus, Kirsi ^b   Palosuo, Timo ^b   Ylikorkala, Olavi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antibodies; Cardiolipin; LDL; Preeclampsia; Serine

Indexed keywords

ANTIBODY; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLSERINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; PROTEINURIA; RISK;

EID: 0029836156     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959609015708     Document Type: Article

References (14)

1. Ishihara M. Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy. Clin Chim Acta 1978;84:l-9.
2. Wickens D, Wilkins MH, Lunec J, Ball G, Dormandy TL. Free radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981;18:158-62.
3. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yaki K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without preeclampsia. Clin Chim Acta 1981;115:155-61.
4. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregnancy 1994;13:1-32.
5. Palinski W, Rosenfeld ME, Ylä-Herttula S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-6.
6. Salonen JT, Ylä-Herttula S, Yamamoto R, et al. Autoantibody against oxidized LDL, and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
7. Branch DW, Mithchell MD, Miller E, Palinski W, Witztum JL. Pre-eclampsia and serum antibodies to oxidized low density lipoprotein. Lancet 1994;343:645-6.
8. Tulppala M, Ailus K, Palosuo T, Ylikorkala O. Antibodies to oxidized low density lipoprotein and to cardiolipin in nonpregnant and pregnant women with a history of habitual abortion. Fertil Steril 1995;64:947-50.
9. Branch DW, Silver RM, Blackwell JL, Reading JL, Scott JR. Outcome of threatened pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992;80:614-20.
10. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical association. Br J Obstet Gynaecol 1993;100:909-13.
11. Vaarala O, Alftan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993;341:923-5.
12. Harris EN, Gharavi AE, Patel SPR, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;86:215-22.
13. CLASP: a randomized trial of low-dose aspirin for prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
14. O'Brien W. The prediction of pre-eclampsia. Clin Obstet Gynecol 1992;35:351-64.